AAPS Main Site
Annual Meeting Home
AAPS Final Program
PSRC Final Program
Past & Future Meetings


Back to 2016 Annual Meeting Posters


A Prospective Study Using Validated Outcome Instruments For Platelet Rich Plasma Therapy for Facial Rejuvenation
Sammy Sinno, MD, Grace Poudrier, B.A., Jennifer Thompson, B.S., Z-hye Lee, M.D., Michael V. Chiodo, M.D., Alexes Hazen, M.D..
New York University, New York, NY, USA.

PURPOSE:
Platelet rich plasma (PRP) therapy can be used for facial rejuvenation. To date, the efficacy and degree of patient satisfaction following PRP treatment has not been evaluated in a standardized fashion with validated patient outcome tools.br>
METHODS:
25 patients were selected for PRP therapy for facial rejuvenation. All patients completed the following FACE-Q scales pre-procedure: appearance appraisal, quality of life, adverse effect checklists for treatment, and process of care. PRP was prepared using a standardized protocol. At 6 weeks post-treatment, another FACE-Q was completed and 2 blinded observers (one plastic surgeon and one dermatologist) were asked to evaluate results, including completion of the Wrinkle Severity Rating Scale.
RESULTS:
All of the patients in this study were female. Compared to pre-procedure FACE-Q scores, patients had higher degrees of satisfaction with appearance appraisal, quality of life, and process of care post-procedure. There were no reported complications. An improvement in Wrinkle Severity Rating was noted between pre- and post-treatment (p<0.05).
CONCLUSION:
This is the first study to use validated instruments to demonstrate the effectiveness of PRP therapy for facial rejuvenation.


Back to 2016 Annual Meeting Posters